Amit A. Joharapurkar
Ahmedabad, UP, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 64 publications
Pair-Feeding Differentiates Feed-Dependent and Pharmacodynamic Effects of Telmisartan in Wistar Rats.
Journal: International journal of toxicology
Published: February 27, 2026
A 1-Month Exploratory Combination Safety and Toxicity Study of Co-Administration of Sitagliptin and Telmisartan in Male Wistar Han Rats.
Journal: International journal of toxicology
Published: August 30, 2025
Evaluation of Repeat Dose Toxicity and Embryo-Fetal Developmental Toxicity of Novel Glucokinase Activator ZYGK1 in Wistar Rats.
Journal: International journal of toxicology
Published: June 27, 2025
Recent Development in Celiac Disease: Pathophysiology, Animal Models and Treatments.
Journal: Drug development research
Published: May 01, 2025
Prolyl hydroxylase inhibitor desidustat improves stroke outcomes via enhancing efferocytosis in mice with chronic kidney disease.
Journal: Experimental neurology
Published: December 13, 2024
HIF-Prolyl Hydroxylase Inhibitor Desidustat Increases Pyruvate Kinase Activity and Reduces Oxidative Stress in Red Blood Cells, Causes Erythrocytosis in Thalassaemic Mice, and Reduces Sickling in Sickle Cell Patient's Blood.
Journal: Drug development research
Published: November 18, 2024
Pharmacological effect of ZYGK1, a novel glucokinase activator, in hyperglycemic and sulfonylurea-resistant type 2 diabetes in mice models.
Journal: Journal of diabetes and its complications
Published: October 24, 2024
Inhibition of alternative complement system and prolyl hydroxylase ameliorates anaemia of inflammation.
Journal: Inflammopharmacology
Published: September 30, 2024
HIF Stabilizer Desidustat Protects against Complement-Mediated Diseases.
Journal: Drug research
Published: July 11, 2024
Prolyl hydroxylase inhibitor desidustat attenuates autoimmune hemolytic anemia in mice.
Journal: International immunopharmacology
Published: July 09, 2024
Desidustat: a novel PHD inhibitor for the treatment of CKD-induced anemia.
Journal: Frontiers in nephrology
Published: July 04, 2024
The Perspective of Using Flow Cytometry for Unpuzzling Hypoxia-Inducible Factors Signalling.
Journal: Drug research
Published: February 13, 2024
Last Updated: 09/26/2026